EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats

Temiday O. Omóbòwálé, Ademola A. Oyagbemi, Ayorinde M. Folasire, Temitayo O. Ajibade, Ebunoluwa R. Asenuga, Olumuyiwa A. Adejumobi, Olufunke E. Ola-Davies, Orotusin Oyetola, Gana James, Adeolu A. Adedapo, Momoh A. Yakubu

Journal of Basic and Clinical Physiology and Pharmacology · 2018-01-26 · 29 (1) · 19-27

DOI: 10.1515/jbcpp-2016-0194 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background: The use of doxorubicin (DOX) as an antineoplastic agent has been greatly limited because of the myriad of toxic sequelae associated with it. The aim of this study was to assess the protective effects of gallic acid (GA) on DOX-induced cardiac toxicity in rats. Methods: Sixty male rats (Wistar strain) were used in this study. They were divided into six groups (A–F) each containing 10 animals. Group A was the control. Rats in Groups B, C, and D were treated with DOX at the dosage of 15 mg/kg body weight i.p. Prior to this treatment, rats in Groups C and D had been treated orally with GA for 7 days at the dosage of 60 and 120 mg/kg, respectively. Animals from Groups E and F received only 60 and 120 mg/kg GA, respectively, which were administered orally for 7 days. Results: The exposure of rats to DOX led to a significant (p

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →